Redwire Signs MOU with Boryung to Support its Trailblazing Humans In Space Program for Global Human Health
24 Avril 2024 - 1:30PM
Business Wire
The Korean pharmaceutical and healthcare investment company aims
to make advancements for global human health through in-space
research
Redwire Corporation (NYSE: RDW), a global leader in microgravity
research, development, and manufacturing announced that it has
signed a memorandum of understanding (MOU) with Boryung
Corporation, a pioneer in innovative solutions based in Korea.
Through the agreement, Redwire will serve as an implementation
partner in support of Boryung’s Humans In Space program, a global
initiative committed to advancing knowledge and innovation that
support the well-being of humanity through space experiments.
Boryung’s Humans In Space program represents a significant
opportunity to advance space research and development to accelerate
novel developments that can lead to improvements in human health
and eventually enable the realization of an interplanetary
civilization. Through the MOU, Redwire intends to facilitate
research experiments on-orbit, funded through the Humans In Space
program, and provide mission management services. Redwire will also
serve as a partner for the third annual Humans In Space challenge,
a global competition for researchers and innovators addressing the
impact of space on human well-being. Challenge winners will be
awarded investments and research awards alongside opportunities to
participate in tailored mentorship programs led by space industry
experts. Last year, 12 participants were awarded. This year’s
challenge launches on April 26.
“Boryung’s Humans In Space program is a pivotal opportunity to
transform the future of space research and drive critical insights
to improve human health by engaging with a global community of
researchers to leverage the benefits of microgravity,” said
President of Redwire In-Space Industries John Vellinger. “Redwire
is excited to see the increased demand from our international
partners looking to develop game-changing research in space as we
continue to lead the way in space commercialization.”
“We are excited to partner with Redwire and leverage their
unparalleled expertise in developing and launching microgravity
research to further the important mission of the Humans In Space
program,” said Jack Lim, the head of Boryung’s New Portfolio
Investment Group. “Humans In Space will pave the way for a
collaborative ecosystem of interplanetary civilization enthusiasts
and the discovery of novel technologies.”
Through this partnership, Boryung will leverage Redwire’s deep
expertise in microgravity payload development and on-orbit
investigation management. With a suite of 10 bioprinting,
manufacturing, and research facilities currently on the
International Space Station (ISS), Redwire will avail its entire
suite of on-orbit capabilities to support research proposals
submitted through the Humans In Space program. Redwire currently
serves as an implementation partner for NASA and the ISS U.S.
National Laboratory, helping to manage and develop investigations
being conducted on the station. Redwire’s portfolio of space
biotech and in-space manufacturing capabilities leverages decades
of spaceflight heritage, with 20 facilities developed for
NASA-crewed vehicles.
About Redwire
Redwire Corporation (NYSE:RDW) is a global space infrastructure
and innovation company enabling civil, commercial, and national
security programs. Redwire’s proven and reliable capabilities
include avionics, sensors, power solutions, critical structures,
mechanisms, radio frequency systems, platforms, missions, and
microgravity payloads. Redwire combines decades of flight heritage
and proven experience with an agile and innovative culture.
Redwire’s approximately 700 employees working from 14 facilities
located throughout the United States and Europe are committed to
building a bold future in space for humanity, pushing the envelope
of discovery and science while creating a better world on Earth.
For more information, please visit redwirespace.com.
About Boryung
Boryung is a healthcare investment company founded in 1957 and
headquartered in Seoul, South Korea. Following the company's
mission to become an indispensable contributor to human health, it
has expanded their business portfolio to the space healthcare
industry. Recognizing space as a new realm for growth, Boryung
acknowledges the increasing number of individuals anticipated to
embark on prolonged space missions, highlighting the importance of
ensuring human survival in the hostile space environment. Hence,
the company believes there will be substantial opportunities to
foster new technologies and meet emerging needs in this field.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424703006/en/
Media Contact: Emily Devine Emily.Devine@redwirespace.com
305-632-9137
OR
Investors: investorrelations@redwirespace.com
904-425-1431
Redwire (NYSE:RDW)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Redwire (NYSE:RDW)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024